Table 1 Relationship between JARID1B protein expression and clinicopathological features in CRC patients

Gender

0.53

 Male

36

2.11 ± 0.85

 Female

18

2.34 ± 0.89

Age (years)

0.71

 ≤ 60

20

2.14 ± 0.93

 > 60

34

2.22 ± 0.83

Tumor size (cm)

0.00^**

 < 5

23

1.61 ± 0.80

 ≥ 5

31

2.62 ± 0.62

Preoperative CEA level

0.00^**

 < 5 ng/mL

40

1.86 ± 0.72

 ≥ 5 ng/mL

15

3.13 ± 0.41

Histologic grade

0.98

 well differentiated

42

2.17 ± 0.89

 poorly differentiated

12

2.26 ± 0.80

T classification

0.00^**

 T1 + T2

17

1.19 ± 0.54

 T3 + T4

37

2.65 ± 0.53

TNM stage

0.38

 I

4

1.57 ± 0.55

 II

14

2.28 ± 1.02

 III

28

2.18 ± 0.88

 IV

8

2.37 ± 0.51

Lymphatic invasion

0.52

 Negative

21

2.12 ± 0.91

 Positive

33

2.24 ± 0.84

Distant metastasis

0.88

 Negative

45

2.16 ± 0.92

 Positive

9

2.33 ± 0.50